June 21, 2015
June 19, 2015
Common Antidotes
Common Antidotes
Drug
|
Antidotes
|
Acetaminophen
|
acetylcysteine
|
Alcohol
|
thiamine
|
Anticholinesterase (insecticides)
|
atropine, pralidoxime
|
Anticholinergics
|
physostigmine
|
Benzodiazepine
|
flumazenil
|
Beta blockers
|
calcium chloride, epinephrine, glucagon
|
Calcium blockers
|
calcium chloride, glucagon
|
Carbon monoxide
|
hyperbaric, oxygen
|
Cyclophosphamide
|
mesna
|
Cyanide
|
amyl nitrate, sodium nitrate, sodium thiosulfate
|
Digoxin
|
digoxin immune fab
|
Dopamine
|
phenotolamine
|
Extrapyrimidal symptoms
|
diphenhydramine
|
Ethylene glycol
|
fomepizole, ethanol
|
Heroin
|
naloxone, nalmefene
|
Heparin
|
protamine sulfate
|
Iron
|
deferoxamine
|
Lead
|
dimercapol, edetate calcium, disodium
|
Methemoglobinemia
|
methylene blue
|
Methotrexate
|
leucovorin
|
Neuromuscular blockade
|
anticholinesterase
|
Potassium
|
albuterol inhaler, insulin/glucose, NaHCO3, kayexalate
|
Serotonin syndrome
|
cyproheptadine
|
Sulfonylurea hypoglycemic
|
octreotide
|
Theophylline
|
pyridoxine
|
Warfarin
|
phytonadione, vitamin K
|
Weight Loss and Gain Medications
Weight Loss Medications
Use with reduced-calorie
diet and increased physical activity
Contrave
(naltrexone/bupropion)
·
Naltrexone is an opiod
antagonist
·
BMI
o 30 kg/m2 or greater (obese) or
o 27 kg/m2 or greater (overweight) + comorbidity
§ Hypertension
§ Type 2 diabetes mellitus
§ Dyslipidemia
·
4-week dose titration
schedule
·
ADR – suicidality,
neuropsychiatric reactions
·
Administration
o NOT cut, chew, or crush Contrave tablets
o NOT take Contrave with high-fat meals à seizures
Belviq (lorcaserin)
·
Serotonin 2C receptor
agonist
·
ADR - serotonin
syndrome, neuroleptic malignant syndrome
·
Administration
o with or without food
Qsymia (phentermine/topiramate)
·
Phentermine - sympathomimetic
amine anorectic
·
Topiramate - antiepileptic
medication
·
ADR - concentration,
memory, and speech difficulties
·
Administration
o With or without food
o Avoid in evening à insomnia
o Avoid alcohol à dizziness and sleepiness
o NOT stop suddenly à seizures
Alli (orlistat)
·
Inhibits gastrointestinal
lipases
·
Administration
o 3 times a day with each main meal containing fat
o Take multivitamin with A,D,E,K
·
ADR – GI effects, gas
Evaluate response after
12 weeks
If 5% weight loss not
seen à stop drug
Weight Loss Bariatric Surgery
- BMI > 35 + comorbidity (hypertension, dyslipidemia, type 2 diabtes)
- BMI > 40
Weight Gain Medications
- Anticonvulsants (carbamazepine, gabapentin, pregabalin, valproic acid, lithium)
- Antidepressants (phenelzine, mirtazapine, paroxetine, amitriptyline, nortriptyline)
- Antihistamines (H1 blockers - cetirizine)
- Antihypertensives (atenolol, propanolol)
- Vasodilators (minoxidil)
- Antipsychotics (chlorpromazine, clozapine, iloperidone, olanzapine, quetiapine, risperidone)
- Corticosteroids
- Hormonals (medroxyprogesterone, megestrol)
- Hypoglycemic (insulin, sulfonylureas, meglitinides, thiazolidinediones)
Source:
http://www.pharmacytimes.com/contributor/anyssa-garza/2015/03/weight-loss-medications-on-the-marketJune 18, 2015
Addyi (filbanserin) Drug Information
· Background
o HSDD 7.7 to 14% of premenopausal women in the US or 5.5 to 8.6 million individuals
o developed by Sprout pharmaceuticals
o approved by FDA on June 4, 2015
· Indication
o hypoactive sexual desire disorder (HSDD)
· Adverse effects
o fainting, nausea, dizziness, sleepiness, low blood pressure
· Mechanism
o mechanism is unknown
o mixed agonist/antagonist effect on postsynaptic serotonergic receptors
o 5HT1A agonist and 5HT2A antagonist
· Concerns
o avoid with alcohol due to concerns about central nervous system depression, hypotension, syncope
o avoid in pregnant women
o avoid with strong or moderate CYP3A4 inhibitors
o prior to HSDD, it was considered for antidepressant indication and though all antidepressants have a black box warning for suicides, there is no sign of increase risk with filbanserin
· Pharmacokinetics
o peak levels reached in 45 to 60 minutes of administration
o peak levels are delayed by 1 to 3 hours with meal
o terminal elimination half-life is 12 hours
o taking with high fat high calorie meal increases exposure 50%
o administration with CYP3A4 inhibitors (ketoconazole, fluconazole) increases filbanserin 4.5 and 7 times, respectively
o hormonal contraceptives are weak inhibitors of CYP3A4, but increase filbanserin 40%
Source:
Pharmacy Times. What to Know About “Female Viagra” Backed by FDA Panel. http://www.pharmacytimes.com/news/what-to-know-about-female-viagra-backed-by-fda-panel#sthash.UW4UXYXR.dpuf
Pharmacy Times. What to Know About “Female Viagra” Backed by FDA Panel. http://www.pharmacytimes.com/news/what-to-know-about-female-viagra-backed-by-fda-panel#sthash.UW4UXYXR.dpuf
June 17, 2015
Drug Information Question
Question: Patient
asked whether her Metformin interacted with an over-the-counter medication she
was taking.
Answer: Based on researching the information in Micromedex, it was found that there was no interaction of concern. To further understand possible over-the-counter medications interactions with Metformin, I read the journal article Drug Interactions of Medications Commonly Used in Diabetes and learned that the major OTC interaction of metformin is cimetidine. Cimetidine causes a 60% increase in peak metformin plasma levels. The incidence of metformin-induced lactic acidosis may reach 0.084 cases per 1000 patient-years, with 50% of the cases being fatal. Other adverse effects associated with metformin are upset stomach, B12 deficiency, and headache.
Source:
Metformin. Drug Interactions. Micromedex
Solutions. Truven Health Analytics, Inc. Greenwood Village, CO.
Available at: http://www.micromedexsolutions.com. Accessed May 22, 2015.
Triplitt, C. "Drug Interactions of Medications
Commonly Used in Diabetes." Diabetes Spectrum (2006):19(4); 202-11.
Subscribe to:
Posts (Atom)